Cargando…

Ameliorative Effect Of Zinc Oxide Nanoparticles Against Dermal Toxicity Induced By Lead Oxide In Rats

BACKGROUND: Recently, several studies demonstrate the possible role of zinc oxide (ZnO) in the protection of several skin diseases, but less is known about the role of ZnO nanoparticles in the inflammatory skin disease. So, this study was designed to confirm the pivotal role of the nano zinc oxide c...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalaf, AA, Hassanen, Eman I, Azouz, Rehab A, Zaki, Amr R, Ibrahim, Marwa A, Farroh, Khaled Y, Galal, Mona K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855620/
https://www.ncbi.nlm.nih.gov/pubmed/31806958
http://dx.doi.org/10.2147/IJN.S220572
_version_ 1783470438716801024
author Khalaf, AA
Hassanen, Eman I
Azouz, Rehab A
Zaki, Amr R
Ibrahim, Marwa A
Farroh, Khaled Y
Galal, Mona K
author_facet Khalaf, AA
Hassanen, Eman I
Azouz, Rehab A
Zaki, Amr R
Ibrahim, Marwa A
Farroh, Khaled Y
Galal, Mona K
author_sort Khalaf, AA
collection PubMed
description BACKGROUND: Recently, several studies demonstrate the possible role of zinc oxide (ZnO) in the protection of several skin diseases, but less is known about the role of ZnO nanoparticles in the inflammatory skin disease. So, this study was designed to confirm the pivotal role of the nano zinc oxide cream in the alleviation of lead oxide (PbO) induced-allergic dermatitis in rats. MATERIALS AND METHODS: Two concentrations (1% and 6%) of ZnONPs creams were prepared and characterized prior to being used in the study. A total number of 30 male Wistar rats were randomly divided into six groups. Group 1 (negative control), groups 2&3 (either 1% or 6% ZnONPs control groups), group 4 (PbO), groups 5&6 (co-treatment of each ZnONPs concentration+PbO). All rats in different groups were observed daily to determine the severity of dermal gross lesions. Histopathological studies, mRNA analysis, and oxidative stress evaluations were performed on the affected skin tissue. Immunohistochemical studies were performed to evaluate the expression of cluster of differentiation CD4, CD8 and intercellular adhesion molecules ICAM-1 in different groups. RESULTS: PbO caused extensive skin oxidative damage manifested by a significant increase in MDA level with a decrease in GSH content and CAT activity. The results of histopathological and immunohistochemical examinations revealed that topical application of PbO for 14 days led to severe allergic dermatitis with remarkable elevations in the number of CD4+ T-helper, CD8+ T-cytotoxic lymphocytes, and ICAM-1 expression. On the other hand, noticeable improvements were recorded in all the previous toxicopathological parameters among the groups treated by either 1% or 6% ZnO-NPs cream. However, the best results were observed in the group treated with 1% ZnO-NPs cream. CONCLUSION: Our findings suggest that 1% of ZnO-NPs cream is safe when applied topically on the inflamed skin. Moreover, it had anti-inflammatory and antioxidant effects so that, it is recommended to use the 1% ZnO-NPs cream to avert the dermal toxicity-induced by PbO.
format Online
Article
Text
id pubmed-6855620
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-68556202019-12-05 Ameliorative Effect Of Zinc Oxide Nanoparticles Against Dermal Toxicity Induced By Lead Oxide In Rats Khalaf, AA Hassanen, Eman I Azouz, Rehab A Zaki, Amr R Ibrahim, Marwa A Farroh, Khaled Y Galal, Mona K Int J Nanomedicine Original Research BACKGROUND: Recently, several studies demonstrate the possible role of zinc oxide (ZnO) in the protection of several skin diseases, but less is known about the role of ZnO nanoparticles in the inflammatory skin disease. So, this study was designed to confirm the pivotal role of the nano zinc oxide cream in the alleviation of lead oxide (PbO) induced-allergic dermatitis in rats. MATERIALS AND METHODS: Two concentrations (1% and 6%) of ZnONPs creams were prepared and characterized prior to being used in the study. A total number of 30 male Wistar rats were randomly divided into six groups. Group 1 (negative control), groups 2&3 (either 1% or 6% ZnONPs control groups), group 4 (PbO), groups 5&6 (co-treatment of each ZnONPs concentration+PbO). All rats in different groups were observed daily to determine the severity of dermal gross lesions. Histopathological studies, mRNA analysis, and oxidative stress evaluations were performed on the affected skin tissue. Immunohistochemical studies were performed to evaluate the expression of cluster of differentiation CD4, CD8 and intercellular adhesion molecules ICAM-1 in different groups. RESULTS: PbO caused extensive skin oxidative damage manifested by a significant increase in MDA level with a decrease in GSH content and CAT activity. The results of histopathological and immunohistochemical examinations revealed that topical application of PbO for 14 days led to severe allergic dermatitis with remarkable elevations in the number of CD4+ T-helper, CD8+ T-cytotoxic lymphocytes, and ICAM-1 expression. On the other hand, noticeable improvements were recorded in all the previous toxicopathological parameters among the groups treated by either 1% or 6% ZnO-NPs cream. However, the best results were observed in the group treated with 1% ZnO-NPs cream. CONCLUSION: Our findings suggest that 1% of ZnO-NPs cream is safe when applied topically on the inflamed skin. Moreover, it had anti-inflammatory and antioxidant effects so that, it is recommended to use the 1% ZnO-NPs cream to avert the dermal toxicity-induced by PbO. Dove 2019-09-20 /pmc/articles/PMC6855620/ /pubmed/31806958 http://dx.doi.org/10.2147/IJN.S220572 Text en © 2019 Khalaf et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Khalaf, AA
Hassanen, Eman I
Azouz, Rehab A
Zaki, Amr R
Ibrahim, Marwa A
Farroh, Khaled Y
Galal, Mona K
Ameliorative Effect Of Zinc Oxide Nanoparticles Against Dermal Toxicity Induced By Lead Oxide In Rats
title Ameliorative Effect Of Zinc Oxide Nanoparticles Against Dermal Toxicity Induced By Lead Oxide In Rats
title_full Ameliorative Effect Of Zinc Oxide Nanoparticles Against Dermal Toxicity Induced By Lead Oxide In Rats
title_fullStr Ameliorative Effect Of Zinc Oxide Nanoparticles Against Dermal Toxicity Induced By Lead Oxide In Rats
title_full_unstemmed Ameliorative Effect Of Zinc Oxide Nanoparticles Against Dermal Toxicity Induced By Lead Oxide In Rats
title_short Ameliorative Effect Of Zinc Oxide Nanoparticles Against Dermal Toxicity Induced By Lead Oxide In Rats
title_sort ameliorative effect of zinc oxide nanoparticles against dermal toxicity induced by lead oxide in rats
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855620/
https://www.ncbi.nlm.nih.gov/pubmed/31806958
http://dx.doi.org/10.2147/IJN.S220572
work_keys_str_mv AT khalafaa ameliorativeeffectofzincoxidenanoparticlesagainstdermaltoxicityinducedbyleadoxideinrats
AT hassanenemani ameliorativeeffectofzincoxidenanoparticlesagainstdermaltoxicityinducedbyleadoxideinrats
AT azouzrehaba ameliorativeeffectofzincoxidenanoparticlesagainstdermaltoxicityinducedbyleadoxideinrats
AT zakiamrr ameliorativeeffectofzincoxidenanoparticlesagainstdermaltoxicityinducedbyleadoxideinrats
AT ibrahimmarwaa ameliorativeeffectofzincoxidenanoparticlesagainstdermaltoxicityinducedbyleadoxideinrats
AT farrohkhaledy ameliorativeeffectofzincoxidenanoparticlesagainstdermaltoxicityinducedbyleadoxideinrats
AT galalmonak ameliorativeeffectofzincoxidenanoparticlesagainstdermaltoxicityinducedbyleadoxideinrats